Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction
Key facts
- Who runs it
- University of Miami
- Where
- Miami, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 59 people enrolled
- Started
- 27 Jun 2022
- Ended
- 14 Mar 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Shock Wave therapy (SWT)
- Platelet Rich Plasma (PRP)
- Sham SWT
- Placebo Saline
- Record updated
- 22 May 2026
Who can take part
- Age
- 30 years to 80 years
- Sex
- Men only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (20)Hide the full registry criteria
Who can take part
- Be Male
- Be 30 to 80 years of age (inclusive)
- Be able to provide written informed consent
- Have a diagnosis of ED due to organic origin for at least 6 months prior to consent
- Sexually active in a stable, heterosexual relationship of more than three months duration
- IIEF-EF score 12-25 at screening
- Agree to attempt sexual intercourse at least 4 times per month for the duration of the study without being under the influence of alcohol or recreational drugs
- Agree to comply with all study related tests/procedures
Who cannot take part
- Previous penile surgery of any kind (except circumcision and condyloma removal), such as penile lengthening, penile cancer surgery, penile plication, grafting
- Previous history of priapism or penile fracture
- Current or previous hormone usage, other than prescribed testosterone, clomiphene or thyroid medication. (Subjects with prior or current use of hormonal treatment for prostate cancer are also excluded
- Any history of significant psychiatric disease, such as bipolar disorder or psychosis, greater than one lifetime episode of major depression, current depression of moderate or greater severity. Patients who are currently using Selective Serotonin Reuptake Inhibitors (SSRI) or psychotropic medications
- Anatomical (Peyronie's Disease or penile curvature that negatively influences sexual activity) or neurological abnormalities in the treatment area
- Patients with generalized polyneuropathy, or neurological conditions irrespective of cause, such as severe diabetes, multiple sclerosis or Parkinson's disease
- Have a serious comorbid illness/condition/behavior that, in the opinion of the investigator, may compromise the safety or compliance of the subject or preclude successful completion of the study
- History of consistent treatment failure with Phosphodiesterase Type 5 (PDE5) inhibitors for therapy of ED
- Abnormal morning serum testosterone level defined as a value lower than 300 ng/dL (±5%) (indicative of untreated hypogonadism), or greater than 1197 ng/dL (±5%)
- Hemoglobin a1c >9%
- Psychogenic ED as determined by study investigator
- Patients using Intracavernosal Injection (ICI) for management of ED
Where in United States
- University of Miami Miller School of MedicineMiami, United States
About the trial
What the trial wants to find out
The purpose of this research study is to evaluate whether the combination of Shock Wave Therapy (SWT) with Platelet Rich Plasma (PRP) is synergistic and can reverse the pathology of microvascular Erectile Dysfunction (ED) and enhance erectile function by improving vasodilation, and endothelial function
The 2 groups in the trial
- SWT plus PRP GroupTreatment being tested
Participants will receive weekly Shockwave Therapy (SWT) and Platelet Rich Plasma (PRP) for 5 weeks. SWT will be administered weekly on Weeks 1, 2, 3, 4, and 5. PRP will be administered on Week 1 and Week 5.
Treatment: Shock Wave therapy (SWT) and Platelet Rich Plasma (PRP)
- Sham SWT plus Placebo Saline GroupPlacebo, for comparison
Participants will receive weekly Sham Shockwave Therapy (SWT) and Placebo Saline Intracavernosal Injection (ICI) for 5 weeks. Sham SWT will be administered weekly on Weeks 1, 2, 3, 4, and 5. Placebo Saline ICI will be administered on Week 1 and Week 5.
Treatment: Sham SWT and Placebo Saline
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Novel Treatment for Microvascular Erectile Dysfunction Combining Shockwave Therapy and Platelet Rich Plasma
- Publications
- Record updated
- 22 May 2026